Inventor · disambiguated record
Michael Demetriou
Also filed as: DEMETRIOU MICHAEL
10 granted patents·4 pending applications·100 citations·filing 1995–2023
88Inventor score
Top patents by PatentIndex Score
14 records- 0182US10925972B2Glycan-dependent immunotherapeutic moleculesUNIV CALIFORNIA·Filed 2016·Granted Feb 23, 2021·3 cites·11 claims
- 0277US5981483ACompositions comprising modulators of cytokines of the TGF-β superfamilyMOUNT SINAI HOSPITAL CORP·Filed 1995·Granted Nov 9, 1999·33 cites·7 claims
- 0377US5821227AModulators of cytokines of the tgf β superfamilyMOUNT SINAI HOSPITAL CORP·Filed 1995·Granted Oct 13, 1998·33 cites·5 claims
- 0472US8658622B2Methods and compositions for preventing and treating a disease related to glycan dysregulationDEMETRIOU MICHAEL·Filed 2006·Granted Feb 25, 2014·4 cites·12 claims
- 0571US2023310637A1Glycan-dependent Immunotherapeutic MoleculesUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0670US5830671AMethod for assaying for modulators of cytokines of the TFG β superfamilyMOUNT SINAI HOSPITAL CORP·Filed 1997·Granted Nov 3, 1998·23 cites·13 claims
- 0767US9775859B2Methods and compositions for preventing and treating a disease related to glycan dysregulationSINAI HEALTH SYS·Filed 2014·Granted Oct 3, 2017·1 cites·13 claims
- 0862US11666660B2Glycan-dependent immunotherapeutic moleculesUNIV CALIFORNIA·Filed 2020·Granted Jun 6, 2023·0 cites·18 claims
- 0959US2025361318A1Improved glycan-dependent immunotherapeutic bi-specific proteins with longer half-lifeUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 1057US2024415858A1Promoting myelination by n-acetylglucosamine and modulation of n-glycan branchingUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 1156US2008227750A1Compositions and methods for regulating receptor clusteringMOUNT SINAI HOSPITAL CORP·Filed 2008·Application pending·0 cites
- 1253US7396529B2Compositions and methods for regulating receptor clusteringMOUNT SINAI HOSPITAL CORP·Filed 2002·Granted Jul 8, 2008·3 cites·4 claims
- 1344US10495646B2N-acetyl glucosamine as a biomarker of MS disease courseUNIV CALIFORNIA·Filed 2016·Granted Dec 3, 2019·0 cites·4 claims
- 1438US11103520B2Analogs of N-acetlyglucosamine and uses thereofUNIV CALIFORNIA·Filed 2015·Granted Aug 31, 2021·0 cites·4 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →